Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Efficacy of rHVT-AI vector vaccine in broilers with passive immunity against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains.

Rauw F, Palya V, Gardin Y, Tatar-Kis T, Dorsey KM, Lambrecht B, van den Berg T.

Avian Dis. 2012 Dec;56(4 Suppl):913-22.

PMID:
23402112
2.

Efficacy of a recombinant HVT-H5 vaccine against challenge with two genetically divergent Indonesian HPAI H5N1 strains.

Soejoedono RD, Murtini S, Palya V, Felföldi B, Mató T, Gardin Y.

Avian Dis. 2012 Dec;56(4 Suppl):923-7.

PMID:
23402113
3.

Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.

Kapczynski DR, Esaki M, Dorsey KM, Jiang H, Jackwood M, Moraes M, Gardin Y.

Vaccine. 2015 Feb 25;33(9):1197-205. doi: 10.1016/j.vaccine.2014.12.028. Epub 2015 Jan 20.

4.

Comparison of the effectiveness of rHVT-H5, inactivated H5 and rHVT-H5 with inactivated H5 prime/boost vaccination regimes in commercial broiler chickens carrying MDAs against HPAI H5N1 clade 2.2.1 virus.

Kilany WH, Hassan MK, Safwat M, Mohammed S, Selim A, VonDobschuetz S, Dauphin G, Lubroth J, Jobre Y.

Avian Pathol. 2015 Oct;44(5):333-41. doi: 10.1080/03079457.2015.1053840.

PMID:
26023824
5.

Further evidence of antigenic drift and protective efficacy afforded by a recombinant HVT-H5 vaccine against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains.

Rauw F, Palya V, Van Borm S, Welby S, Tatar-Kis T, Gardin Y, Dorsey KM, Aly MM, Hassan MK, Soliman MA, Lambrecht B, van den Berg T.

Vaccine. 2011 Mar 21;29(14):2590-600. doi: 10.1016/j.vaccine.2011.01.048. Epub 2011 Feb 1.

PMID:
21292007
6.

Efficacy of a Recombinant Turkey Herpesvirus H5 Vaccine Against Challenge With H5N1 Clades 1.1.2 and 2.3.2.1 Highly Pathogenic Avian Influenza Viruses in Domestic Ducks (Anas platyrhynchos domesticus).

Pantin-Jackwood MJ, Kapczynski DR, DeJesus E, Costa-Hurtado M, Dauphin G, Tripodi A, Dunn JR, Swayne DE.

Avian Dis. 2016 Mar;60(1):22-32. doi: 10.1637/11282-091615-Reg.1.

PMID:
26953940
7.

Influence of maternal immunity on vaccine efficacy and susceptibility of one day old chicks against Egyptian highly pathogenic avian influenza H5N1.

Abdelwhab EM, Grund C, Aly MM, Beer M, Harder TC, Hafez HM.

Vet Microbiol. 2012 Feb 24;155(1):13-20. doi: 10.1016/j.vetmic.2011.08.004. Epub 2011 Aug 7.

PMID:
21920677
8.

Protection conferred by recombinant turkey herpesvirus avian influenza (rHVT-H5) vaccine in the rearing period in two commercial layer chicken breeds in Egypt.

Kilany W, Dauphin G, Selim A, Tripodi A, Samy M, Sobhy H, VonDobschuetz S, Safwat M, Saad M, Erfan A, Hassan M, Lubroth J, Jobre Y.

Avian Pathol. 2014;43(6):514-23. doi: 10.1080/03079457.2014.966302. Epub 2014 Nov 14.

PMID:
25245772
9.

Potency of a recombinant NDV-H5 vaccine against various HPAI H5N1 virus challenges in SPF chickens.

Lardinois A, Steensels M, Lambrecht B, Desloges N, Rahaus M, Rebeski D, van den Berg T.

Avian Dis. 2012 Dec;56(4 Suppl):928-36.

PMID:
23402114
10.

Passive protection afforded by maternally-derived antibodies in chickens and the antibodies' interference with the protection elicited by avian influenza-inactivated vaccines in progeny.

De Vriese J, Steensels M, Palya V, Gardin Y, Dorsey KM, Lambrecht B, Van Borm S, van den Berg T.

Avian Dis. 2010 Mar;54(1 Suppl):246-52.

PMID:
20521640
11.

Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.

Jadhao SJ, Lee CW, Sylte M, Suarez DL.

Vaccine. 2009 Oct 19;27(44):6247-60. doi: 10.1016/j.vaccine.2009.07.110. Epub 2009 Aug 15.

PMID:
19686695
12.

Prime-boost vaccination with recombinant H5-fowlpox and Newcastle disease virus vectors affords lasting protection in SPF Muscovy ducks against highly pathogenic H5N1 influenza virus.

Niqueux E, Guionie O, Amelot M, Jestin V.

Vaccine. 2013 Aug 28;31(38):4121-8. doi: 10.1016/j.vaccine.2013.06.074. Epub 2013 Jul 8.

PMID:
23845804
13.

Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.

Pavlova SP, Veits J, Keil GM, Mettenleiter TC, Fuchs W.

Vaccine. 2009 Jan 29;27(5):773-85. doi: 10.1016/j.vaccine.2008.11.033. Epub 2008 Nov 28.

PMID:
19041677
14.

Protective efficacy of H5 inactivated vaccines in meat turkey poults after challenge with Egyptian variant highly pathogenic avian influenza H5N1 virus.

Kilany WH, Abdelwhab EM, Arafa AS, Selim A, Safwat M, Nawar AA, Erfan AM, Hassan MK, Aly MM, Hafez HM.

Vet Microbiol. 2011 May 12;150(1-2):28-34. doi: 10.1016/j.vetmic.2010.12.016. Epub 2010 Dec 14. Erratum in: Vet Microbiol. 2014 May 14;170(1-2):178.

PMID:
21236607
15.

Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate.

Grund C, Abdelwhab el-SM, Arafa AS, Ziller M, Hassan MK, Aly MM, Hafez HM, Harder TC, Beer M.

Vaccine. 2011 Jul 26;29(33):5567-73. doi: 10.1016/j.vaccine.2011.01.006. Epub 2011 Jan 15.

PMID:
21244859
16.

Efficacy of a fowlpox-vectored avian influenza H5 vaccine against Asian H5N1 highly pathogenic avian influenza virus challenge.

Bublot M, Pritchard N, Cruz JS, Mickle TR, Selleck P, Swayne DE.

Avian Dis. 2007 Mar;51(1 Suppl):498-500.

PMID:
17494618
17.

Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.

Kilany WH, Safwat M, Mohammed SM, Salim A, Fasina FO, Fasanmi OG, Shalaby AG, Dauphin G, Hassan MK, Lubroth J, Jobre YM.

PLoS One. 2016 Jun 15;11(6):e0156747. doi: 10.1371/journal.pone.0156747. eCollection 2016.

18.

Expression of HA of HPAI H5N1 virus at US2 gene insertion site of turkey herpesvirus induced better protection than that at US10 gene insertion site.

Gao H, Cui H, Cui X, Shi X, Zhao Y, Zhao X, Quan Y, Yan S, Zeng W, Wang Y.

PLoS One. 2011;6(7):e22549. doi: 10.1371/journal.pone.0022549. Epub 2011 Jul 27.

19.

Multiple dose vaccination with heterologous H5N2 vaccine: immune response and protection against variant clade 2.2.1 highly pathogenic avian influenza H5N1 in broiler breeder chickens.

Abdelwhab EM, Grund C, Aly MM, Beer M, Harder TC, Hafez HM.

Vaccine. 2011 Aug 26;29(37):6219-25. doi: 10.1016/j.vaccine.2011.06.090. Epub 2011 Jul 13.

PMID:
21745517
20.

Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China.

Connie Leung YH, Luk G, Sia SF, Wu YO, Ho CK, Chow KC, Tang SC, Guan Y, Malik Peiris JS.

Vaccine. 2013 Aug 2;31(35):3536-42. doi: 10.1016/j.vaccine.2013.05.076. Epub 2013 Jun 19.

PMID:
23791547

Supplemental Content

Support Center